SBIO

ALPS Medical Breakthroughs ETFALPS Funds$70.64+1.54 (+2.24%)

AUM $220.6MER 0.50%NAV $66.84Holdings 103Inception Dec 2014

Price Chart

Key Statistics

Previous Close

$69.09

Day Range

$69.48$70.85

52-Week Range

$34.04$70.79

Avg Volume

38.8K

Dividend Yield

2.29%

Expense Ratio

0.50%

AUM

$220.6M

Shares Outstanding

3.2M

ETF Grades

?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.

Sector Breakdown

Sector	Weight %
Healthcare	100.00%

Country Allocation

Country	Weight %
United States	89.00%
Canada	3.12%
United Kingdom	1.92%
Netherlands	1.65%
China	1.45%
Belgium	1.33%
Germany	0.67%
Singapore	0.49%
Switzerland	0.37%

Fund Information

Issuer: ALPS Funds
Category: Healthcare
Types: Healthcare
Inception Date: Dec 30, 2014
Exchange: NYSE_ARCA
Description: The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).

Similar ETFs

Symbol	Name	AUM	Expense Ratio	Holdings
SCHD	Schwab U.S. Dividend Equity ETF	$108.74B	0.06%	103
IWM	iShares Russell 2000 ETF	$82.83B	0.19%	1,965
XLV	State Street Health Care Select Sector SPDR ETF	$43.85B	0.08%	60
VHT	Vanguard Health Care ETF	$20.40B	0.09%	411
VTWO	Vanguard Russell 2000 ETF	$18.60B	0.06%	1,969

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund issued by ALPS Funds that launched on Dec 30, 2014. It currently manages $220.6M in assets under management. The fund charges an expense ratio of 0.50%. The fund holds 103 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 32.0% of the fund

Rank	Symbol	Name	Weight %	Shares	Market Value
1	CRNX	Crinetics Pharmaceuticals Inc.	4.56%	119,051	$10.1M
2	APGE	Apogee Therapeutics Inc.	4.26%	69,943	$9.4M
3	CGON	CG oncology Inc.	3.38%	99,688	$7.4M
4	ORKA	Oruka Therapeutics Inc.	3.34%	68,047	$7.4M
5	XENE	Xenon Pharmaceuticals Inc.	3.18%	109,102	$7.0M
6	DNTH	Dianthus Therapeutics Inc.	3.07%	61,733	$6.8M
7	TVTX	Travere Therapeutics Inc.	2.93%	105,028	$6.5M
8	ACAD	ACADIA Pharmaceuticals Inc.	2.49%	193,319	$5.5M
9	DFTX	Definium Therapeutics Inc.	2.45%	123,264	$5.4M
10	EWTX	Edgewise Therapeutics Inc.	2.38%	121,692	$5.3M
11	MANE	VeraDermics Inc.	2.37%	47,118	$5.2M
12	RLAY	Relay Therapeutics Inc.	2.22%	245,913	$4.9M
13	DYN	Dyne Therapeutics Inc.	2.20%	186,901	$4.9M
14	DNLI	Denali Therapeutics Inc.	2.02%	179,404	$4.5M
15	GPCR	Structure Therapeutics Inc.	1.99%	80,356	$4.4M

Page 1 of 3

Detailed Returns

Period	ETF	Cat. Avg
1D	+2.24%	—
1W	+4.46%	—
1M	+8.94%	—
3M	+32.81%	—
6M	+36.85%	—
YTD	+41.13%	—
1Y	+107.99%	—
3Y	+138.36%	—
5Y	+58.12%	—

Moving Averages

20-Day MA

$66.10

Above 20-Day MA

50-Day MA

$63.21

Above 50-Day MA

200-Day MA

$54.15

Above 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$70.79

Current Price

$70.64

52-Week Low

$34.04

$34.04$70.79

Current Yield

2.29%

Annual Dividend

$1.2764

Frequency

1x/year

Last Ex-Date

Dec 19, 2024

Dividend History

Ex-Date	Amount	Pay Date
Dec 19, 2024	$1.1735	Dec 26, 2024
Dec 21, 2023	$0.0711	Dec 27, 2023
Dec 19, 2019	$0.0160	Dec 27, 2019
Dec 19, 2019	$0.0158	Dec 27, 2019
Dec 20, 2018	$0.7841	Dec 27, 2018
Dec 20, 2018	$0.7840	Dec 27, 2018
Dec 21, 2017	$0.5795	Dec 28, 2017
Dec 21, 2017	$0.5790	Dec 28, 2017

Dividend Payments Over Time

Category Comparison

Metric	SBIO	Healthcare(222 ETFs)	Healthcare(24 ETFs)
Fund Info
Expense Ratio	0.50%	0.62%	0.47%
AUM	$220.6M	$1.98B	$764.6M
Dividend Yield	2.29%	3.92%	1.61%
Avg Volume	38.8K	441.0K	96.9K
Holdings	103	167	169
Performance
1-Month Return	—	-6.87%	—
6-Month Return	—	-5.23%	—
YTD Return	+38.21%	+16.78%	+13.69%
1-Year Return	—	-5.91%	—

Compare with Another ETF

Search for an ETF to compare with SBIO:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.